# Y-mAbs Reports Second Quarter 2025 Financial Results and Recent Corporate Developments
Canonical URL: https://biopharmsignal.com/news/YMAB/y-mabs-reports-second-quarter-2025-financial-results-and-recent-corporate-developments
Ticker: YMAB
Company: Y-mAbs
Source: Y-mAbs
Published: 2025-08-08 10:35 EST
Original Source URL: https://ir.ymabs.com
## Summary

Reported Total Revenues of $19.5 million for the second quarter of 2025, exceeding the high end of the Company’s guidance range of between $17 million and $19 million SERB Pharmaceuticals to acquire Y-mAbs in $412.0 million transaction; transaction expected to close by the fourth quarter of 2025,  

## Article Body
Reported Total Revenues of $19.5 million for the second quarter of 2025, exceeding the high end of the Company’s guidance range of between $17 million and $19 million SERB Pharmaceuticals to acquire Y-mAbs in $412.0 million transaction; transaction expected to close by the fourth quarter of 2025,
## Recent Company News
- 2025-09-16 12:41 EST — [SERB Pharmaceuticals Completes Acquisition of Y-mAbs Therapeutics](https://biopharmsignal.com/news/YMAB/serb-pharmaceuticals-completes-acquisition-of-y-mabs-therapeutics) — Source: Y-mAbs
- 2025-08-08 10:35 EST — [Y-mAbs Reports Second Quarter 2025 Financial Results and Recent Corporate Developments](https://biopharmsignal.com/news/YMAB/y-mabs-reports-second-quarter-2025-financial-results-and-recent-corporate-developments) — Source: Y-mAbs
- 2025-08-07 11:30 EST — [Y-mAbs to Announce Second Quarter 2025 Financial and Operating Results on August 8, 2025](https://biopharmsignal.com/news/YMAB/y-mabs-to-announce-second-quarter-2025-financial-and-operating-results-on-august-8-2025) — Source: Y-mAbs
- 2025-08-05 12:30 EST — [SERB Pharmaceuticals Agrees to Acquire Y-mAbs Therapeutics](https://biopharmsignal.com/news/YMAB/serb-pharmaceuticals-agrees-to-acquire-y-mabs-therapeutics) — Source: Y-mAbs
- 2025-05-28 10:35 EST — [Y-mAbs Hosts Virtual Radiopharmaceutical R&D Update Highlighting Clinical Progress and Expanded Pipeline](https://biopharmsignal.com/news/YMAB/y-mabs-hosts-virtual-radiopharmaceutical-randd-update-highlighting-clinical-progress-and-expanded-pipeline) — Source: Y-mAbs
## Related News
- 2026-07-29 13:00 EST — ENLV — [Enlivex Management to Host Webinar to Discuss Capital Strategy, Rain Protocol Treasury Strategy, and Recent Clinical Milestones](https://biopharmsignal.com/news/ENLV/enlivex-management-to-host-webinar-to-discuss-capital-strategy-rain-protocol-tre-5921a627)
- 2026-07-29 12:30 EST — PRGO — [Perrigo to Present at the Canaccord 46th Annual Growth Conference](https://biopharmsignal.com/news/PRGO/perrigo-to-present-at-the-canaccord-46th-annual-growth-conference-40431922)
- 2026-07-29 12:30 EST — LIXT — [NOMAD Announces Operational Deployment of Two Mobile Battery Systems by DSO Electric Cooperative](https://biopharmsignal.com/news/LIXT/nomad-announces-operational-deployment-of-two-mobile-battery-systems-by-dso-elec-7fc12a2c)
- 2026-07-29 12:30 EST — RNXT — [RenovoRx to Host Second Quarter 2026 Financial Results and Business Highlights Conference Call on August 12th at 4:30 p.m. ET](https://biopharmsignal.com/news/RNXT/renovorx-to-host-second-quarter-2026-financial-results-and-business-highlights-c-8bed10ec)
- 2026-07-29 12:25 EST — ICCM — [IceCure: SIO Petitions NCCN to Include Cryoablation in Breast Cancer Treatment Guidelines, Citing IceCure's FDA Clearance  of ProSense®](https://biopharmsignal.com/news/ICCM/icecure-sio-petitions-nccn-to-include-cryoablation-in-breast-cancer-treatment-gu-bec46cd3)